LGM

Logos Global Management Portfolio holdings

AUM $749M
1-Year Est. Return 18.94%
This Quarter Est. Return
1 Year Est. Return
+18.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$563M
AUM Growth
-$292M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$35.5M
2
+$26.1M
3
+$21.8M
4
KROS icon
Keros Therapeutics
KROS
+$20.4M
5
ETNB icon
89bio
ETNB
+$18.2M

Top Sells

1
+$42.3M
2
+$37M
3
+$31.5M
4
INSM icon
Insmed
INSM
+$31.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$27.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$1.26B
$4.72M 0.84%
240,000
+100,000
IMVT icon
27
Immunovant
IMVT
$2.97B
$4.7M 0.84%
275,000
-25,000
JBIO
28
Jade Biosciences
JBIO
$425M
$3.51M 0.62%
40,000
ACRS icon
29
Aclaris Therapeutics
ACRS
$208M
$3.4M 0.6%
2,222,222
UNCY icon
30
Unicycive Therapeutics
UNCY
$83.7M
$2.92M 0.52%
507,893
TRVI icon
31
Trevi Therapeutics
TRVI
$1.28B
$2.67M 0.47%
424,715
-825,285
ATXS icon
32
Astria Therapeutics
ATXS
$675M
$2.67M 0.47%
500,000
RAPP
33
Rapport Therapeutics
RAPP
$1.13B
$2.1M 0.37%
208,910
CBIO
34
Crescent Biopharma
CBIO
$209M
$1.13M 0.2%
54,000
SEPN
35
Septerna Inc
SEPN
$972M
$777K 0.14%
134,202
ALLK
36
DELISTED
Allakos
ALLK
$660K 0.12%
2,900,000
ARTV
37
Artiva Biotherapeutics
ARTV
$138M
$435K 0.08%
145,089
SLDB icon
38
Solid Biosciences
SLDB
$448M
$370K 0.07%
+100,000
NUVB.WS icon
39
Nuvation Bio Inc Warrants
NUVB.WS
$56.1M
$15.9K ﹤0.01%
66,666
ALKS icon
40
Alkermes
ALKS
$4.98B
– –
-500,000
APGE icon
41
Apogee Therapeutics
APGE
$3.64B
– –
-300,000
APLS icon
42
Apellis Pharmaceuticals
APLS
$3.06B
– –
-500,000
ARVN icon
43
Arvinas
ARVN
$676M
– –
-700,000
INSM icon
44
Insmed
INSM
$34.2B
– –
-450,000
JAZZ icon
45
Jazz Pharmaceuticals
JAZZ
$8.17B
– –
-175,000
MRUS icon
46
Merus
MRUS
$7.18B
– –
-750,000
NBIX icon
47
Neurocrine Biosciences
NBIX
$13.6B
– –
-200,000
PCVX icon
48
Vaxcyte
PCVX
$5.52B
– –
-300,000
PLRX icon
49
Pliant Therapeutics
PLRX
$98.2M
– –
-750,000
SYRE icon
50
Spyre Therapeutics
SYRE
$1.71B
– –
-500,000
1
2
3